We also offer the NEW COVID vaccination (Comirnaty 30mcg XBB.1.5)
Subject to eligibility criteria, needs to be at least 6 months after your previous booster/COVID infection. Available at Queen St store.
Book your FLU vaccinations now.
You can choose the times that are available and NOT BLACKED OUT.
Please come early to your appointment so you can fill in the consent form.
You can choose between the TWO Unichem stores depending on availability.
1) Unichem Waiuku Medical Pharmacy
2) Unichem Waiuku Pharmacy
If you're unsure call us and we can help you.
Please choose from the list
1) FLU Vaccinations (NON-FUNDED Flucelvac Quad 16 years and over) $44.99 Improved protection
A cell based flu vaccine offering 5-19% greater vaccine effectiveness compared to standard flu vaccine. Designed to be an exact match to circulating flu strains. NOT FUNDED
2) FLU Vaccinations (Non-Funded FLUAD QUAD 65 years and older). $49.99 Increased protection
Please choose this if you want the NON_FUNDED FLUAD QUAD vaccination. FLUAD® Quad is specifically designed for people aged 65 years old or over and is the only flu vaccine that contains MF59® Adjuvant, which helps your body create more antibodies to help fight influenza viruses. Less chance of contracting the flu compared with the standard flu vaccine.
NOTE : If you are over 65 years please use the other booking option if you want the FUNDED brand. ( without the MF59 Adjuvant)
3) FLU Vaccinations (NON-FUNDED Influvac Tetra 16 years and over) $39.99
If you are over 16 and ineligible for Funded vaccinations and have to pay. This is the option to choose unless you want the Fluclevac that gives increased protection.
4) FUNDED FLU vaccinations are FREE for people 65 years ( Influvac Tetra).
Please choose this option if you are 65 and over and want it FREE
5) FUNDED FLU Vaccinations FREE (Approved Health Conditions + Pregnancy - any trimester).
Please use this option if you have a Recognised & Approved health condition (as per Ministry of Health requirements) that allows you a FREE flu vaccination. )
Funded influenza vaccine is available each year for people who meet the following criteria set by Pharmac:* 1. All people 65 years of age and over; or 2. People under 65 years of age who: • have any of the following cardiovascular diseases: - ischaemic heart disease, or - congestive heart failure, or - rheumatic heart disease, or - congenital heart disease, or - cerebrovascular disease; or • have either of the following chronic respiratory diseases: - asthma, if on a regular preventative therapy , or - other chronic respiratory disease with impaired lung function, or • have diabetes; or • have chronic renal disease; or • have any cancer, excluding basal and squamous skin cancers if not invasive; or • have any of the following other conditions: - autoimmune disease , or - immune suppression or immune deficiency, or - HIV, or - transplant recipient, or - neuromuscular and CNS diseases/disorder,d or - haemoglobinopathiese , or - children on long-term aspirin, or - a cochlear implant, or - errors of metabolism at risk of major metabolic decompensation, or - pre and post splenectomy, or - Down syndrome, or • are pregnant (any trimester); or
3. People under 65 years of age who: • have any of the following serious mental health conditions: - schizophrenia, or - major depressive disorder, or - bipolar disorder, or - schizoaffective disorder, or • are currently accessing secondary or tertiary mental health and addiction services. • asthma not requiring regular preventative therapy • hypertension and/or dyslipidaemia without evidence of end-organ disease.
Explanatory notes: a. People with asthma who are prescribed a preventer inhaler are entitled to a funded influenza vaccination, regardless of whether they are adherent with treatment. b. Chronic respiratory diseases include chronic bronchitis, chronic obstructive pulmonary disease, cystic fibrosis, emphysema. c. Autoimmune diseases may include coeliac disease, Crohn’s disease, Grave’s disease, Hashimoto’s thyroiditis, lupus, rheumatoid arthritis. Immune suppression or immune deficiency includes disease modifying anti-rheumatic drugs (DMARDS) or targeted biologic therapies. d. Neuromuscular and CNS diseases/disorders include cerebral palsy, congenital myopathy, epilepsy, hydrocephaly, motor neurone disease, multiple sclerosis, muscular dystrophy, myasthenia gravis, Parkinson’s disease, spinal cord injury. e. Haemoglobinopathies include sickle cell anaemia, thalassemia.
6) COVID vaccination (Comirnaty 30mcg XBB.1.5)
Subject to eligibility criteria, needs to be at least 6 months after your previous booster/COVID infection. Available at Queen St store.
The monovalent Comirnaty 30mcg XBB.1.5 vaccine stimulates strong antibody responses against current variants of the Omicron XBB-lineage and the BA.2.86 variant in people who have previously received earlier vaccines.
Receipt of the Comirnaty 30mcg XBB.1.5 can provide additional protection beyond that received by prior doses or infection and restore protection after waning.
As the monovalent XBB.1.5 vaccines were only recently introduced vaccine effectiveness estimates are still very limited, but available data suggests they provide some enhanced protection compared to bivalent variant-containing vaccines and monovalent index virus (original) vaccines. An American study found Comirnaty 30mcg XBB.1.5 vaccine provided 54% increased protection against symptomatic SARS-CoV-2 infection (including JN.1 variants) compared with no receipt of updated vaccine in adults over 18 years of age. In a study from Denmark, it was associated with a 76·1% reduced risk of COVID-19 hospitalisation in the short term in a population vaccinated with a booster dose during the previous season.
The main benefit of vaccination is to reduce the risk of severe COVID-19 infection including hospitalisation and death. Additional doses have the greatest additional benefit in those who have a higher risk of severe infection – older people, those with other health conditions (including pregnant people), Māori and Pacific peoples and those living with deprivation. We also know protection against severe infection declines with time - hence the need for additional doses.
A single additional dose is recommended for individuals aged 16 years and over, after completing the primary course. This is given at least six months after previous COVID‑19 vaccination or COVID‑19 infection.
Additional doses of Comirnaty 30mcg XBB.1.5 continue to be recommended from six months after last COVID-19 vaccination for those aged 12 and over who are eligible because of a higher risk of severe infection. Additional doses also continue to be available for healthy people aged 30 and over.
The interval recommended from prior COVID-19 infection or vaccination is six months, as we know that protection against severe disease persists for up to at least six months. Having a dose earlier has limited benefit. Note, the eligibility criteria have not changed.
As a reminder, additional COVID-19 doses are available for those:
Unichem Waiuku Medical Pharmacy
30B/26-30 Constable Road, Waiuku 2123, Auckland
Opening Hours: Mon - Fri 8:30am - 5:30pm | Saturday 9am - 1pm | Sunday Closed
Phone: 09 235 0922 | Email: waiukumed@unichem.co.nz
